{
    "2021-01-12": [
        [
            {
                "time": "2018-01-02",
                "original_text": "AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "outpaces",
                        "stock market gains"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-15",
                "original_text": "Allergan Aesthetics Enters Into Option to Acquire Cypris Medical",
                "features": {
                    "keywords": [
                        "Allergan",
                        "aesthetics",
                        "acquire",
                        "Cypris Medical"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "cosmetics"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-08",
                "original_text": "AbbVie to Host Fourth-Quarter and Full-Year 2020 Earnings Conference Call",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "earnings",
                        "conference call"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07-14",
                "original_text": "Dragonfly Therapeutics Announces AbbVie Opt-In of TriNKET™ Immunotherapy Drug Candidate",
                "features": {
                    "keywords": [
                        "Dragonfly Therapeutics",
                        "AbbVie",
                        "opt-in",
                        "TriNKET™",
                        "immunotherapy"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}